Thc Therapeutics

(OTC) THCT

Current Price$0.00

Market Cap$36,200

Since IPO (2017)-100%

5 Year-100%

1 Year+800%

1 Month+350%

Thc Therapeutics Financials at a Glance

Market Cap

$36,200

Revenue (TTM)

$0.00

Net Income (TTM)

$562.78K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

21.78 (High)

Dividend

$0.00

Beta (Volatility)

21.78 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Dividend

$0.00

Beta (Volatility)

21.78 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

THCT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Thc Therapeutics

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Scott A. Cox

Website

thct.io

Headquarters

Las Vegas, NV 89135, US

THCT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

15%

Return on Assets

-30%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$36.20K

Shares Outstanding

40.27M

Volume

Avg. Volume

10.68K

Financials (TTM)

Gross Profit

$1.39K

Operating Income

$493.91K

EBITDA

$492.52K

Operating Cash Flow

$85.43K

Capital Expenditure

$0.00

Free Cash Flow

$85.43K

Cash & ST Invst.

$10.00

Total Debt

$791.44K

Thc Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$344.00

-1.2%

Gross Margin

0.00%

N/A

Market Cap

$36.20K

N/A

Market Cap/Employee

$36.20K

N/A

Employees

N/A

Net Income

$104.62K

+10.9%

EBITDA

$123.30K

+8.2%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Net Cash

$730.94K

+0.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$731.79K

+0.0%

Return on Assets

-29.79%

N/A

Return on Invested Capital

15.39%

N/A

Free Cash Flow

$137.06K

-6192.9%

Operating Cash Flow

$137.06K

-6193.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NMXSNet Medical Xpress Solutions, Inc.

NMXSNet Medical Xpress Solutions, Inc.$0.00+0.00%

QMDTQuick-Med Technologies, Inc.

QMDTQuick-Med Technologies, Inc.$0.00+0.00%

REMIRemedent, Inc.

REMIRemedent, Inc.$0.00+0.00%

EMGEEmergent Health Corp

EMGEEmergent Health Corp$0.00+0.00%

CYPSCyclo3pss Corporation

CYPSCyclo3pss Corporation$0.00+0.00%

NMRDNemaura Medical Inc.

NMRDNemaura Medical Inc.$0.00+42.86%

TNGNQTengion, Inc.

TNGNQTengion, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.71+2.34%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.12+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.74+0.01%

XNDUXanadu Quantum Technologies

XNDUXanadu Quantum Technologies$14.68-0.59%

ADTADT

ADTADT$7.15-0.05%

FFord Motor Company

FFord Motor Company$11.49-0.03%

GMEGameStop

GMEGameStop$24.28-0.08%

Questions About THCT

What is the current price of Thc Therapeutics?

Thc Therapeutics is trading at $0.00 per share.

What is the 52-week range for Thc Therapeutics?

Over the past 52 weeks, Thc Therapeutics has traded between $0.00 and $0.10.

How much debt does Thc Therapeutics have?

As of the most recent reporting period, Thc Therapeutics reported total debt of $876,895.

How much cash does Thc Therapeutics have on hand?

Thc Therapeutics reported $35 in cash and cash equivalents in its most recent financial results.

What is Thc Therapeutics’s dividend yield?

Thc Therapeutics does not currently have a dividend yield.

Thc Therapeutics

Thc Therapeutics Financials at a Glance

THCT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Thc Therapeutics

THCT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Thc Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About THCT

What is the current price of Thc Therapeutics?

What is the 52-week range for Thc Therapeutics?

How much debt does Thc Therapeutics have?

How much cash does Thc Therapeutics have on hand?

What is Thc Therapeutics’s dividend yield?

Premium Investing Services